NEW YORK, April 24, 2015 /PRNewswire/ — Small Cap IR issues analyst report. PositiveID Corporation (OTCQB: PSID) is an emerging growth company and developer of biological detection and diagnostic systems for America’s homeland defense and the global healthcare market. The company specializes in developing microfluidic systems for the automated preparation of and performance of biological assays in order to be able to detect biological threats and outbreaks, whether airborne, in a healthcare setting, or at the point of need.
PositiveID develops biological detection and diagnostic systems, which includes its M-BAND and Firefly Dx systems, which use real-time polymerase chain reaction (PCR) chemistry. PCR amplifies a sample’s DNA and copies it billions of times. PCR is also used every day to diagnose diseases, identify bacteria and viruses. Real-time PCR is one of the most sensitive and specific bio-detection capabilities available today. Positive ID is primarily focused on its M-BAND airborne bio-threat detector, a development under contract with the U.S. Department of Homeland Security (“DHS”) Science & Technology directorate and it’s Firefly Dx System, which is designed to deliver molecular diagnostic results from a sample in less than 30 minutes using a portable, handheld system.
For analyst comments and recommendation on PositiveID Corp. the please follow the link. There is no cost obligation required to view analyst brief.
Copy and paste to browser may be required.
This report was prepared for informational purposes only. Affiliated parties involved with producing and issuing this report have not been compensated in any form by profiled company. A full disclaimer can be found by viewing the full analyst report.
About Small Cap IR
Small Cap IR makes the connection between sophisticated investors and high quality micro-small cap companies that are currently undervalued. We are an issuer of reports written by experienced financial analysts and who provide a straight forward assessment of a profiled company. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges. For more information and services provided beyond this release please use contact information provided below.
This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward- looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.
Content is researched, written and reviewed on a best-effort basis by a 3rd party research analyst. However, we are only human and make mistakes. This report was prepared for informational purposes only. Affiliated parties involved with producing and issuing this report have not been compensated in any form by the profiled company or any related party. A full disclaimer can be found by viewing the full analyst report. We do not engage in high frequency trading or hold any positions of profiled company.
For more information and services provided beyond this release please use contact information provided below. If you notice any errors or omissions, please notify us below.
A full disclaimer can be found by viewing the analyst report. If you wish to have a company covered in more detail by our team, or wish to learn more about our services, please contact us at firstname.lastname@example.org.
Media Relations Contact:
SOURCE Small Cap IR